What type of study is this?

This is a Human Clinical Trial study (also classified as: RCT).

What question did this study set out to answer?

To identify improvement opportunities in PRO reporting quality for RCTs of lymphoma and multiple myeloma.

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Analysis finds PRO reporting quality in lymphoma RCTs remains unchanged, suggesting need for improved timeliness.

To identify improvement opportunities in PRO reporting quality for RCTs of lymphoma and multiple myeloma.
Analyzed 83 RCTs involving PRO endpoints in lymphoma and multiple myeloma.
Used CONSORT-PRO checklist for quality assessment.
Calculated CONSORT-PRO scores to evaluate reporting quality over time.
Median CONSORT-PRO score was 9.5, indicating moderate reporting quality.
Only 1.2% of studies had PROs as primary endpoints.
Publication of a secondary PRO paper was linked to higher reporting quality.

Shah et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark